The studies mentioned in this review highlight several targets through which TAMs may be targeted therapeutically such as CSF-1, IL-6, NFκB and suggest that depletion of TAMs, or re-education to an immunostimulatory phenotype, may result in a decrease in tumor growth and spread as well as enhance response to chemotherapy. Here, IL6 is linked to neoplasm.